<--- Back to Details
First PageDocument Content
COX-2 inhibitors / Cardiology / British National Formulary / Cardiovascular disease / Pharmacy / Pharmacology
Date: 2015-01-13 15:22:39
COX-2 inhibitors
Cardiology
British National Formulary
Cardiovascular disease
Pharmacy
Pharmacology

2013 University Health Network & Mount Sinai CARDIOVASCULAR PHARMACOTHERAPY HANDBOOK RESPONSIBILITIES OF THE CARDIOVASCULAR SUBCOMMITTEE OF THE PHARMACY AND THERAPEUTICS COMMITTEE 1.

Add to Reading List

Source URL: www.pie.med.utoronto.ca

Download Document from Source Website

File Size: 96,09 KB

Share Document on Facebook

Similar Documents

RETAIL PHARMACY CASE STUDY  Retail Pharmacy and Healthcare Distributor Case Study Global powerhouse gains visibility, strategic power and clarity with KeyedIn Projects SaaS solution

RETAIL PHARMACY CASE STUDY Retail Pharmacy and Healthcare Distributor Case Study Global powerhouse gains visibility, strategic power and clarity with KeyedIn Projects SaaS solution

DocID: 1xVz3 - View Document

Case Study: WESTERN MARYLAND PHARMACY Improving Clinical Outcomes and Decreasing Acetaminophen Costs by 78% with Diver Platform

Case Study: WESTERN MARYLAND PHARMACY Improving Clinical Outcomes and Decreasing Acetaminophen Costs by 78% with Diver Platform

DocID: 1xTm3 - View Document

PDF Document

DocID: 1xQi5 - View Document

PDF Document

DocID: 1xNTr - View Document

PDF Document

DocID: 1xIyF - View Document